192 related articles for article (PubMed ID: 10580182)
21. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
Lloyd CE; Becker D; Ellis D; Orchard TJ
Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics.
Morrish NJ; Stevens LK; Fuller JH; Jarrett RJ; Keen H
Diabetologia; 1991 Aug; 34(8):590-4. PubMed ID: 1936663
[TBL] [Abstract][Full Text] [Related]
23. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
[TBL] [Abstract][Full Text] [Related]
24. NIDDM and its metabolic control predict coronary heart disease in elderly subjects.
Kuusisto J; Mykkänen L; Pyörälä K; Laakso M
Diabetes; 1994 Aug; 43(8):960-7. PubMed ID: 8039603
[TBL] [Abstract][Full Text] [Related]
25. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
26. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
Orchard TJ; Forrest KY; Ellis D; Becker DJ
Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
[TBL] [Abstract][Full Text] [Related]
27. Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.
Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1014-9. PubMed ID: 10195930
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus is associated with early chronic venous disorder of the lower extremities in Chinese patients with cardiometabolic risk factors.
Zhong J; Chen J; Zhao ZG; He HB; Yan ZC; Liu DY; Zhu ZM; Ni YX
Diabetes Metab Res Rev; 2014 Sep; 30(6):505-12. PubMed ID: 24700718
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Olson JC; Erbey JR; Williams K; Forrest KY; Smithline Kinder L; Ellis D; Becker DJ
Diabetes Care; 2003 May; 26(5):1374-9. PubMed ID: 12716791
[TBL] [Abstract][Full Text] [Related]
30. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population.
Donnan PT; Donnelly L; New JP; Morris AD
Diabetes Care; 2006 Jun; 29(6):1231-6. PubMed ID: 16732001
[TBL] [Abstract][Full Text] [Related]
31. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(6):307-13. PubMed ID: 11120454
[TBL] [Abstract][Full Text] [Related]
32. Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
Juutilainen A; Kortelainen S; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetes Care; 2004 Dec; 27(12):2898-904. PubMed ID: 15562204
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of coronary risk factors in non-insulin dependent (type 2) diabetics.
Walia M; Agarwal AK; Shah P; Yadav R; Singh CP; Yadav P
J Assoc Physicians India; 1999 Nov; 47(11):1051-5. PubMed ID: 10862311
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.
Hu D; Jablonski KA; Sparling YH; Robbins DC; Lee ET; Welty TK; Howard BV
Ann Epidemiol; 2002 Feb; 12(2):79-85. PubMed ID: 11880214
[TBL] [Abstract][Full Text] [Related]
35. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
[TBL] [Abstract][Full Text] [Related]
36. Effects of systolic and diastolic blood pressures on incident coronary heart disease and all-cause death in Chinese women with Type 2 diabetes: the Hong Kong Diabetes Registry.
Ma RC; Yang X; Ko GT; So WY; Kong AP; Ho CS; Lam CW; Chow CC; Tong PC; Chan JC
J Diabetes; 2009 Jun; 1(2):90-8. PubMed ID: 20929505
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences.
Ruppert K; Roberts MS; Orchard TJ; Zgibor JC
Diabetes Res Clin Pract; 2007 Nov; 78(2):234-7. PubMed ID: 17467846
[TBL] [Abstract][Full Text] [Related]
38. Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.
Whiteley L; Padmanabhan S; Hole D; Isles C
Diabetes Care; 2005 Jul; 28(7):1588-93. PubMed ID: 15983305
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
40. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.
Hu G; Jousilahti P; Tuomilehto J
Eur Heart J; 2007 Dec; 28(24):3059-66. PubMed ID: 17981826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
